SIAP
INSY

Sterling Investment Advisors (Pennsylvania)’s Insys Therapeutics, Inc. INSY Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-250
Closed – – 460
2019
Q2 		$0 Hold
250
– – ﹤0.01% 461
2019
Q1 		$1K Hold
250
– – ﹤0.01% 411
2018
Q4 		$0 Hold
250
– – ﹤0.01% 450
2018
Q3 		$3K Hold
250
– – ﹤0.01% 403
2018
Q2 		$1K Hold
250
– – ﹤0.01% 385
2018
Q1 		$2K Hold
250
– – ﹤0.01% 361
2017
Q4 		$2K Sell
250
-4,750
-95% -$31.1K ﹤0.01% 339
2017
Q3 		$44K Buy
+5,000
New +$51.6K 0.03% 190

Sterling Investment Advisors (Pennsylvania)'s INSY Position: Q3 2019 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 250 shares.

Sterling Investment Advisors (Pennsylvania) first reported a position in INSY in Q3 2017 and held it in 8 quarters. The position peaked at $44K in Q3 2017. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 250 Insys Therapeutics, Inc. shares in Q3 2019.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Insys Therapeutics, Inc. in Q3 2017 and held it in 8 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Insys Therapeutics, Inc. position peaked at $44K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2019, filed 15 Oct 2019.